Concepedia

Rohinton S. Tarapore

RS

30

Publications

2K

Citations

26

H-Index

2000

Active since

Affiliations

Oncoceutics (United States)(Current)

The University of Texas MD Anderson Cancer Center

University of Pennsylvania

University of Wisconsin–Madison

Chimerix (United States)

Rohinton S. Tarapore is an author at Oncoceutics (United States) specializing in medicine, tumor biology, and cancer research.

ORCID

Top concepts

Publications per year

2000–2024

30

Publications

30

Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer

Imtiaz A. Siddiqui, Mohammad Asim, Bilal Bin Hafeez et al. · The FASEB Journal · 2010 · 232 citations

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

S. Andrew, Rohinton S. Tarapore, Matthew D. Hall et al. · Journal of Neuro-Oncology · 2019 · 187 citations

, , +8

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji et al. · Cancer Discovery · 2023 · 130 citations · Full text

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

Evan Cantor, Kyle Wierzbicki, Rohinton S. Tarapore et al. · Neuro-Oncology · 2022 · 108 citations · Full text

Lupeol inhibits proliferation of human prostate cancer cells by targeting  -catenin signaling

Mohammad Saleem, Imtıyaz Murtaza, Rohinton S. Tarapore et al. · Carcinogenesis · 2009 · 90 citations · Full text

Rows per page

1–5 of 30